Diversify Advisory Services LLC Takes Position in Astera Labs, Inc. $ALAB

Diversify Advisory Services LLC purchased a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 7,518 shares of the company’s stock, valued at approximately $2,124,000.

Several other institutional investors and hedge funds also recently modified their holdings of ALAB. Eurizon Capital SGR S.p.A. acquired a new stake in Astera Labs in the fourth quarter worth approximately $18,708,000. Swedbank AB raised its stake in shares of Astera Labs by 76.8% in the 4th quarter. Swedbank AB now owns 78,140 shares of the company’s stock worth $12,999,000 after buying an additional 33,940 shares in the last quarter. Mitsubishi UFJ Morgan Stanley Securities Co. Ltd. acquired a new stake in shares of Astera Labs in the fourth quarter valued at $499,000. Revere Asset Management Inc bought a new position in Astera Labs during the fourth quarter valued at about $589,000. Finally, Banque Cantonale Vaudoise boosted its stake in Astera Labs by 85.9% during the first quarter. Banque Cantonale Vaudoise now owns 6,990 shares of the company’s stock valued at $766,000 after buying an additional 3,229 shares in the last quarter. Institutional investors own 60.47% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on ALAB. Rothschild & Co Redburn began coverage on shares of Astera Labs in a research report on Friday, May 1st. They set a “neutral” rating and a $153.00 price objective for the company. Stifel Nicolaus boosted their target price on shares of Astera Labs from $260.00 to $460.00 and gave the stock a “buy” rating in a report on Wednesday, June 24th. Weiss Ratings raised shares of Astera Labs from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, May 21st. Needham & Company LLC raised their target price on shares of Astera Labs from $260.00 to $425.00 and gave the stock a “buy” rating in a report on Wednesday, August 5th. Finally, Evercore restated an “outperform” rating and issued a $297.00 price target on shares of Astera Labs in a research report on Tuesday, May 19th. One analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and eight have issued a Hold rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $333.00.

Insider Buying and Selling

In related news, COO Sanjay Gajendra sold 400,000 shares of the firm’s stock in a transaction that occurred on Thursday, May 21st. The stock was sold at an average price of $290.30, for a total value of $116,120,000.00. Following the transaction, the chief operating officer directly owned 5,064,213 shares of the company’s stock, valued at approximately $1,470,141,033.90. This trade represents a 7.32% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Jack R. Lazar sold 10,000 shares of Astera Labs stock in a transaction that occurred on Thursday, June 4th. The shares were sold at an average price of $355.17, for a total transaction of $3,551,700.00. Following the completion of the transaction, the director directly owned 75,688 shares in the company, valued at approximately $26,882,106.96. This represents a 11.67% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 631,979 shares of company stock valued at $215,479,247 in the last three months. 10.40% of the stock is currently owned by corporate insiders.

Astera Labs Trading Down 5.2%

Shares of NASDAQ ALAB opened at $303.44 on Wednesday. Astera Labs, Inc. has a one year low of $97.89 and a one year high of $499.48. The business has a 50-day moving average price of $356.72 and a two-hundred day moving average price of $242.75. The firm has a market capitalization of $52.64 billion, a PE ratio of 150.22 and a beta of 3.84.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings results on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, beating the consensus estimate of $0.69 by $0.11. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The business had revenue of $392.40 million for the quarter, compared to analysts’ expectations of $360.85 million. During the same period in the previous year, the company posted $0.44 EPS. Astera Labs’s revenue was up 104.5% on a year-over-year basis. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. Research analysts anticipate that Astera Labs, Inc. will post 2.7 EPS for the current year.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.